Industry regrets "unilateral" decision to disband GHTF
This article was originally published in SRA
A number of medical technology industry associations that are represented on the Global Harmonization Task Force have expressed their disappointment at what they say is "the unilateral decision taken without advance consultation by regulatory authorities to disband the organisation".
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The European public assessment report for Novartis's advanced breast cancer therapy, Piqray (alpelisib), includes some interesting insights into what EU regulators are looking for in drug company clinical trials.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.